Stewart, A. Keith
University Health Network · Princess Margaret Cancer Centre
4 papers on CoChatORCID 0000-0001-8638-6933
Most cited papers
- Verified
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Berdeja, J. G., Madduri, D., Usmani, S. Z., Jakubowiak, A., Agha, M., Cohen, A. D., Stewart, A. K., Hari, P., Htut, M., Lesokhin, A., et al. (2021) · The Lancet
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 1,756
- Verified
Oral selinexor-dexamethasone for triple-class refractory multiple myeloma.
Chari, A., Vogl, D. T., Gavriatopoulou, M., Nooka, A. K., Yee, A. J., Huff, C. A., Moreau, P., Dingli, D., Cole, C., Lonial, S., et al. (2019) · New England Journal of Medicine
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 666
- Verified
Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
Martin, T., Usmani, S. Z., Berdeja, J. G., Agha, M., Cohen, A. D., Hari, P., Avigan, D., Deol, A., Htut, M., Lesokhin, A., et al. (2023) · Journal of Clinical Oncology
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 663
- Verified
Protein levels of genes encoded on chromosome 21 in fetal down syndrome brain: challenging the gene dosage effect hypothesis (part II)
Cheon, M. S., Bajo, M., Kim, S. H., Claudio, J. O., Stewart, A. K., Patterson, D., Kruger, W. D., Kondoh, H., & Lubec, G. (2003) · Amino Acids
Down syndrome and intellectual disability researchGenetics and Neurodevelopmental Disorders
Cited by 35
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free